Area of research
Radiology, Nuclear Medicine and Imaging · Biomedical Engineering
Research interest
Research focused on GSK-3 and Hyperphosphorylation, with related work in Neurotoxicity, Protein kinase B, Hippocampus. Notable publications include 'Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer', 'Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia', and 'Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11 month old APP/PS1 transgenic mice: A Western blot study'.
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia
Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11 month old APP/PS1 transgenic mice: A Western blot study
Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus
Retraction Note to: Fuzhisan, a Chinese Herbal Medicine, Inhibits Beta-Amyloid-Induced Neurotoxicity and Tau Phosphorylation Through Calpain/Cdk5 Pathway in Cultured Cortical Neurons
Retraction notice to “Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation” [J. Ethnopharmacol. 133 (2011) 1109–1116]